1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : PHARMACEUTICALS

Aarti Drugs Ltd.

NSE: AARTIDRUGS | BSE: 524348

Falling Comet

Check Buy or Sell

508.40 -3.05 (-0.60%)

39.61% Fall from 52W High

46,577 NSE+BSE Volume

NSEJan 20, 2022 10:29 AM

Watchlist

Portfolio

Alert

Share

9S
9W
2O
5T
2,191.6

Operating Revenue TTM Cr

High in industry

211.1

Net profit TTM Cr

Below industry Median

9.6

Net Profit Margin TTM %

Below industry Median

7.1

Revenue Growth (TTM)

Below industry Median

-14.7

Profit Growth (TTM)

Negative Net Profit TTM Growth %



Documents
15 Nov, 2021 BSE INDIA
AARTI DRUGS LTD. - 524348 - Announcement under Regulation 30 (LODR)-Earnings Ca…
AARTI DRUGS LTD. - 524348 - Announcement under Regulation 30 (LODR)-Earnings Ca…
pdflink
31 Aug, 2021 BSE INDIA
AARTI DRUGS LTD. - 524348 - Announcement under Regulation 30 (LODR)-Earnings Ca…
AARTI DRUGS LTD. - 524348 - Announcement under Regulation 30 (LODR)-Earnings Ca…
pdflink
28 Jul, 2021 TRENDLYNE
Earnings Call for Q1FY22 of Aarti Drugs
Earnings Call for Q1FY22 of Aarti Drugs
videolink
09 Jun, 2021 BSE INDIA
Aarti Drugs Ltd - 524348 - Announcement under Regulation 30 (LODR)-Earnings Cal…
Aarti Drugs Ltd - 524348 - Announcement under Regulation 30 (LODR)-Earnings Cal…
pdflink
17 May, 2021 TRENDLYNE
Earnings Call for Q4FY21 of Aarti Drugs
Earnings Call for Q4FY21 of Aarti Drugs
videolink
27 Jan, 2021 TRENDLYNE
Earnings Call for Q3FY21 of Aarti Drugs
Earnings Call for Q3FY21 of Aarti Drugs
videolink
26 Oct, 2020 TRENDLYNE
Earnings Call for Q2FY21 Aarti Drugs
Earnings Call for Q2FY21 Aarti Drugs
videolink
27 Jul, 2020 TRENDLYNE
Earnings Call Transcript - Q1FY21 for Aarti Drugs
Earnings Call Transcript - Q1FY21 for Aarti Drugs
videolink
18 May, 2020 TRENDLYNE
Earnings Call Transcript - Q4FY20 for Aarti Drugs
Earnings Call Transcript - Q4FY20 for Aarti Drugs
videolink
All Earnings Calls
Annual Report Mar-2021
pdf
Annual Report Mar-2020
pdf
Annual Report Mar-2019
pdf
Annual Report Mar-2018
pdf
Annual Report Mar-2017
pdf
Annual Report Mar-2016
pdf
Annual Report Mar-2015
pdf
Annual Report Mar-2014
pdf
Annual Report Mar-2013
pdf
Annual Report Mar-2012
pdf
Annual Report Mar-2011
pdf
Annual Report Mar-2010
pdf
27 Oct, 2021 BSE INDIA
AARTI DRUGS LTD. - 524348 - Announcement under Regulation 30 (LODR)-Investor Pr…
AARTI DRUGS LTD. - 524348 - Announcement under Regulation 30 (LODR)-Investor Pr…
pdflink
28 Jul, 2021 BSE INDIA
AARTI DRUGS LTD. - 524348 - Announcement under Regulation 30 (LODR)-Investor Pr…
AARTI DRUGS LTD. - 524348 - Announcement under Regulation 30 (LODR)-Investor Pr…
pdflink
17 May, 2021 BSE INDIA
AARTI DRUGS LTD. - 524348 - Announcement under Regulation 30 (LODR)-Investor Pr…
AARTI DRUGS LTD. - 524348 - Announcement under Regulation 30 (LODR)-Investor Pr…
pdflink
28 Jan, 2021 BSE INDIA
AARTI DRUGS LTD. - 524348 - Announcement under Regulation 30 (LODR)-Investor Pr…
AARTI DRUGS LTD. - 524348 - Announcement under Regulation 30 (LODR)-Investor Pr…
pdflink
02 Nov, 2020 BSE INDIA
AARTI DRUGS LTD. - 524348 - Announcement under Regulation 30 (LODR)-Investor Pr…
AARTI DRUGS LTD. - 524348 - Announcement under Regulation 30 (LODR)-Investor Pr…
pdflink
17 Aug, 2020 BSE INDIA
AARTI DRUGS LTD. - 524348 - Announcement under Regulation 30 (LODR)-Investor Pr…
AARTI DRUGS LTD. - 524348 - Announcement under Regulation 30 (LODR)-Investor Pr…
pdflink
23 Jun, 2020 BSE INDIA
AARTI DRUGS LTD. - 524348 - Investor Presentation
AARTI DRUGS LTD. - 524348 - Investor Presentation
pdflink
29 May, 2019 BSE INDIA
AARTI DRUGS LTD. - 524348 - Announcement under Regulation 30 (LODR)-Investor Pr…
AARTI DRUGS LTD. - 524348 - Announcement under Regulation 30 (LODR)-Investor Pr…
pdflink